Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2PIRTOBRUTINIB

02 8SELPERCATINIB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : JAYPIRCA

Antibody Engineering
Not Confirmed
arrow

Brand Name : JAYPIRCA

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : JAYPIRCA

Dosage Strength : 50MG

Approval Date : 2023-01-27

Application Number : 216059

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

02

Brand Name : JAYPIRCA

Antibody Engineering
Not Confirmed
arrow

Brand Name : JAYPIRCA

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : JAYPIRCA

Dosage Strength : 100MG

Approval Date : 2023-01-27

Application Number : 216059

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

03

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : CAPSULE; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 40MG

Approval Date : 2020-05-08

Application Number : 213246

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

04

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : CAPSULE; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 80MG

Approval Date : 2020-05-08

Application Number : 213246

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

05

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 40MG

Approval Date : 2024-04-10

Application Number : 218160

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

06

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 80MG

Approval Date : 2024-04-10

Application Number : 218160

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

07

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 120MG

Approval Date : 2024-04-10

Application Number : 218160

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

08

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : TABLET; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 160MG

Approval Date : 2024-04-10

Application Number : 218160

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

blank

09

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : CAPSULE; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 40MG

Approval Date :

Application Number : 218160

RX/OTC/DISCN :

RLD :

TE Code :

blank

10

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Brand Name : RETEVMO

Antibody Engineering
Not Confirmed
arrow

Loxo Oncology Inc

Dosage Form : CAPSULE; ORAL

Proprietary Name : RETEVMO

Dosage Strength : 80MG

Approval Date :

Application Number : 218160

RX/OTC/DISCN :

RLD :

TE Code :

blank